Thea Teale wrote to Christine Dora on 30 March, in response to her query about testing, that it was "a balance between sticking to what we were asked to do & anticipating further demands. I am still inclined not to cover testing in the body of the report."

Christine Dora sent an email to Dr Keel and Lynda Towers stating that she did not understand half of the papers obtained from Professor Cash and asked for advice in relation to the sequence of events regarding testing as might relate to their investigation.

Thea Teale sent an email to Christine Dora expressing concern about what might come out of the papers which Professor Cash had provided and that they "look carefully for any suggestions that the state of knowledge was other than that which the SNBTS have offered."

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland, Professor Ludlam sought advice on whether haemophilia directors should be looking back to try and identify what had happened to people whose whereabouts and status were unknown. Lynda Towers referred to the Central Legal Office and said that haemophilia directors should follow their advice on whether any further investigation or tracking down of patients was necessary.

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Professor Ludlam that DDAVP could have been used from 1979 but that this was a matter of clinical judgement and "patients were desperate at that time to be prescribed concentrate as this allowed them to treat themselves at home."

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Dr Henry Watson of Aberdeen Haemophilia Centre that the clinician "would have to make the decision of whether to hand the patient a host of information or outline the benefits/risks of particular products."

Subscribe to